Literature DB >> 14558142

MIG1-dependent and MIG1-independent regulation of GAL gene expression in Saccharomyces cerevisiae: role of Imp2p.

Adriana Alberti1, Tiziana Lodi, Iliana Ferrero, Claudia Donnini.   

Abstract

Imp2p (Yil154c) is a transcriptional activator involved in glucose derepression of the maltose, galactose and raffinose utilization pathways and in resistance to thermal, oxidative or osmotic stress. We analysed the role of Imp2 in the regulation of GAL genes. Imp2 was shown to have a positive effect on glucose derepression of Leloir pathway genes and their activator gene GAL4. The effect of Imp2 on galactose metabolism was shown to be partially dependent on Mig1p. The Mig1-independent role depends on Nrg1p. However, disruption of both MIG1 and NRG1 only partially relieves the glucose repression of GAL genes in the Deltaimp2 mutant, indicating that Imp2 must also have other function(s). Moreover, the interaction between IMP2 and GAL6/BLH1, a recently isolated gene involved in the regulation of GAL genes that shares with Imp2 the ability to protect cells from the glycopeptide bleomycin, was also analysed. The results suggest a major role of Imp2 in a GAL6-independent pathway. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14558142     DOI: 10.1002/yea.1025

Source DB:  PubMed          Journal:  Yeast        ISSN: 0749-503X            Impact factor:   3.239


  2 in total

1.  Characterization of a new multigene family encoding isomaltases in the yeast Saccharomyces cerevisiae, the IMA family.

Authors:  Marie-Ange Teste; Jean Marie François; Jean-Luc Parrou
Journal:  J Biol Chem       Date:  2010-06-18       Impact factor: 5.157

2.  MIG1 Glucose Repression in Metabolic Processes of Saccharomyces cerevisiae: Genetics to Metabolic Engineering.

Authors:  Iraj Alipourfard; Nelly Datukishvili; Salar Bakhtiyari; Karimeh Haghani; Laura Di Renzo; Renata Costa de Miranda; David Mikeladze
Journal:  Avicenna J Med Biotechnol       Date:  2019 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.